Partners and Investors

• Founded in 2008
• Business model that includes both discovery and clinical development operations.
• Successful history of partnering and raising capital – $25 million investment from Bukwang Pharmaceuticals for Phase 2b Diabetes development.
• Seeking investors and partners to co-develop promising pipeline of derisked clinical stage assets in NASH, Diabetes and Parkinson's Disease